期刊文献+

Eplerenone inhibits atrial fibrosis in mutant TGF-β1 transgenic mices.. 被引量:4

Eplerenone inhibits atrial fibrosis in mutant TGF-β1 transgenic mice
原文传递
导出
摘要 The purpose of the present study was to study the impacts of eplerenone (EPL), an antagonist of mineralocorticoid receptors (MR), on atrial fibrosis in a mouse model with selective fibrosis in the atrium, and to explore the possible mechanisms. Using mutant TGF-β1 transgenic (Tx) mice, we first demonstrated that EPL inhibited atrial fibrosis specifically and decreased mac- rophage accumulation in the atria of these mice. Results from immunohistochemistry and western blotting showed that EPL attenuated protein expression of fibrosis-related molecules such as connective tissue growth factor (CTGF) and fibronectin in the atria of Tx mice. In culture, EPL inhibited gene expression of fibrosis-related molecules such as fibronectin, ct-SMA, and CTGF in TGF-β1-stimulated atrial fibroblasts, Finally, using a co-culture system, we showed that TGF-β1 stimulated atrial fi- broblasts induced migration of macrophages and this was blocked by EPL. EPL also blocked TGF-β1 induced gene expression of intedeukin-6 (IL-6) in atrial fibroblasts. Therefore, we conclude that EPL attenuated atrial fibrosis and macrophage infiltra- tion in Tx mice. TGF-I31 and IL-6 were involved in the impacts of EPL on activation of atrial fibroblasts and interactions be- tween fibroblasts and macrophages. The purpose of the present study was to study the impacts of eplerenone(EPL), an antagonist of mineralocorticoid receptors(MR), on atrial fibrosis in a mouse model with selective fibrosis in the atrium, and to explore the possible mechanisms. Using mutant TGF-β1 transgenic(Tx) mice, we first demonstrated that EPL inhibited atrial fibrosis specifically and decreased macrophage accumulation in the atria of these mice. Results from immunohistochemistry and western blotting showed that EPL attenuated protein expression of fibrosis-related molecules such as connective tissue growth factor(CTGF) and fibronectin in the atria of Tx mice. In culture, EPL inhibited gene expression of fibrosis-related molecules such as fibronectin, α-SMA, and CTGF in TGF-β1-stimulated atrial fibroblasts. Finally, using a co-culture system, we showed that TGF-β1-stimulated atrial fibroblasts induced migration of macrophages and this was blocked by EPL. EPL also blocked TGF-β1-induced gene expression of intedeukin-6(IL-6) in atrial fibroblasts. Therefore, we conclude that EPL attenuated atrial fibrosis and macrophage infiltration in Tx mice. TGF-β1 and IL-6 were involved in the impacts of EPL on activation of atrial fibroblasts and interactions between fibroblasts and macrophages.
出处 《Science China(Life Sciences)》 SCIE CAS CSCD 2016年第10期1042-1047,共6页 中国科学(生命科学英文版)
基金 supported by National Nature Science Foundation of China(30871083) Doctoral Innovation Fund Projects from Shanghai Jiao Tong University School of Medicine(BXJ201442)
关键词 EPLERENONE atrial fibrosis atrial fibroblasts MACROPHAGES TGF-Β1 TGF-β1 转基因小鼠 基因突变 纤维化 心房 Western印迹 成纤维细胞 结缔组织生长因子
  • 相关文献

参考文献2

二级参考文献57

  • 1LAN Yu & YANG Xiao State Key Laboratory of Proteomics, Genetic Laboratory of Development and Diseases, Institute of Biotechnology, Beijing 100071, China.The role of Smad signaling in vascular and hematopoietic development revealed by studies using genetic mouse models[J].Science China(Life Sciences),2010,53(4):485-489. 被引量:4
  • 2Gibbons GH, Dzau V.I. The emerging concept of vascular remodeling. N Engl J Med, 1994,330: 1431-1438.
  • 3Glagov S. Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med, 1987,316: 1371-1375.
  • 4Jones EA, Ie Noble F. Eichmann A. What determines blood vessel structure') Genetic prespecification vs. hemodynamics. Physiology, 2006,21: 388-395.
  • 5Potente M, Gerhardt H, Carmeliet P. Basic and therapeutic aspects of angiogenesis. Cell. 2011,146: 873-887.
  • 6Stenmark KR, Yeager ME, EI Kasmi KC Nozik-Grayck E, Gerasirnovskaya EV, Li M, Riddle SR, Frid MG. The adventitia: essential regulator of vascular wall structure and function. Annu Rev Physiol, 2013, 75: 23-47.
  • 7Stenmark KR, Frid MG, Yeager M, Li M, Riddle S, McKinsey T, EI Kasrni KC Targeting the adventitial microenvironment in pulmonary hypertension: a potential approach to therapy that considers epigenetic change. Pulmon circular, 2012, 2: 3-14.
  • 8Duan SZ, Usher MG, Mortensen RM. Peroxisome proliferatoractivated receptor-gamma-mediated effects in the vasculature. Circ Res, 2008,102: 2);3-294.
  • 9Swirski FK, Pittet MJ, Kircher MF, Aikawa E, Jaffer FA, Libby P. Weissleder R. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc Natl Acad Sci USA, 2006, 103:10340-10345.
  • 10Robbins CS, Hilgendorf I, Weber GF. Theurl L Iwamoto v, Figueiredo JL, Gorbatov R. Sukhova GK, Gerhardt LM, Smyth D, Zavitz CC Shikatani EA, Parsons M, van Rooijen N, Lin HY, Husain M, Libby p, Nahrendorf M, Weissleder R, Swirski FK. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med, 20\3,19: 1166--1172.

共引文献13

同被引文献11

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部